Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 5, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Adrian Dillon will resign from his job as executive VP of finance and administration and CFO of Agilent Technologies to become chief financial and administrative officer at Skype. He will be replaced at the beginning of April by Didier Hirsch, who currently is VP of corporate controllership and taxes and who will serve as acting CFO.

Hirsch has been at Agilent since its inception, and before that he was CFO of Hewlett-Packard-Europe, Middle East, and Africa. "Moving forward with Didier as interim CFO, we are assigning a proven veteran performer to this key position while we complete our search for Adrian's replacement," Agilent President and CEO Bill Sullivan said in a statement.

Pacific Biosciences last week appointed Susan Barnes as its first chief financial officer.

She formerly was senior VP of finance and CFO of Intuitive Surgical and previously served as managing director of the private equity group at Jeffries & Company, among other positions.

Brian McKelligon joined Ion Torrent Systems in January as vice president for North American sales and Nader Pourmand has joined the company's scientific advisory board. McKelligon formerly was vice president of sales and marketing at SwitchGear Genomics, and he directed sales and business development activities at Affymetrix, Ingenuity Systems, and Incyte.

Pourmand is an assistant professor of biomolecular engineering at the University of California, Santa Cruz, and director of the university's genome sequencing center.

Compugen has given its co-CEOs Anat Cohen-Dayag and Martin Gerstel new positions, with Cohen-Dayag taking on the roles of CEO and president, and Gerstel will serve as chairman. Cohen-Dayag will replace Dov Hershberg, who will remain a company director.

Cohen-Dayag formerly was VP for diagnostic biomarkers and drug targets and of R&D at the company. Gerstel has been at Compugen since 1997 as chairman of the board, and before that he was CEO and co-chairman of Alza.

Dale Sanders, a biology professor and department head at the University of York, will be the new director and CEO of the John Innes Centre, one of the institutes of the Biotechnology and Biological Sciences Research Council (BBSRC).

Sanders is succeeding Chris Lamb, who died in August 2009. Sanders has been at York since 1983, and he is recognized as a leading authority on the mechanisms involved in transporting chemicals across cell membranes in plants.

Affymetrix has tapped Jami Nachtsheim and Nelson Chan to serve on its board of directors, and naming Nachtsheim to its compensation committee and Chan to its audit committee. Both new directors will receive an initial grant of 20,000 stock options, according to a filing with the US Securities and Exchange Commission.

Nachtsheim worked at Intel for 20 years and retired in 2000, most recently serving as corporate VP of sales and marketing and director of worldwide marketing. Chan was CEO of Magellan Navigation, and he worked at SanDisk in senior VP positions.

Affy also said in the SEC filing that John Young plans to retire from the board of directors in May, at the time of the company's 2010 stockholders meeting.

Carl Severinghaus has joined molecular diagnostic company Vermillion's board of directors. He currently is president of Tecan Americas, and he has been at Tecan in a variety of positions, over most of the past two decades.

Enigma Diagnostics has appointed Joel Centeno to be VP Regulatory and Quality for the US. Centeno served as director of quality affairs and regulatory affairs at Hologic.

New York University School of Medicine Professor Robert Boorstein will join Enzo Biochem as medical director of Enzo Clinical Labs, a clinical reference lab serving the New York City area.

Boorstein has directed the consolidation of labs in the South Manhattan and North Manhattan Healthcare Networks and the NYC Health and Hospital Corporation, and he oversaw the Bellevue Hospital laboratory, Enzo said.

Pat White will join the National Institutes of Health as associate director for legislative policy and analysis. White most recently was VP for federal relations at the Association of American Universities. Before that he held the post of director of legislative relations for the Federation of American Societies for Experimental Biology, and he has worked in the White House Office of Science and Technology Policy and as chief of staff for Michigan Congressman Robert Davis.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.